Literature DB >> 22492210

Unresectable Hepatocellular Carcinoma Due to Portal Venous Thrombosis: Focal Stereotactic Body Radiation Therapy Can Promote Resectability.

Andrew Y Lee1, Tianming Wu1, Michael W Vannier2, Giuliano Testa3, Stanley L Liauw4.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22492210     DOI： 10.1007/s12029-012-9387-0

Source DB:  PubMed          Journal:  J Gastrointest Cancer


× No keyword cloud information.
  20 in total

Review 1.  Radiation-associated liver injury.

Authors:  Charlie C Pan; Brian D Kavanagh; Laura A Dawson; X Allen Li; Shiva K Das; Moyed Miften; Randall K Ten Haken
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-03-01       Impact factor: 7.038

2.  Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials.

Authors:  J M Llovet; J Bustamante; A Castells; R Vilana; M del C Ayuso; M Sala; C Brú; J Rodés; J Bruix
Journal:  Hepatology       Date:  1999-01       Impact factor: 17.425

3.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

4.  The safety and efficacy of high-dose proton beam radiotherapy for hepatocellular carcinoma: a phase 2 prospective trial.

Authors:  David A Bush; Zeid Kayali; Roger Grove; Jerry D Slater
Journal:  Cancer       Date:  2011-01-24       Impact factor: 6.860

5.  The treatment of recurrent brain metastases with stereotactic radiosurgery.

Authors:  J S Loeffler; H M Kooy; P Y Wen; H A Fine; C W Cheng; E G Mannarino; J S Tsai; E Alexander
Journal:  J Clin Oncol       Date:  1990-04       Impact factor: 44.544

6.  Treatment of portal vein tumor thrombosis of hepatoma patients with either stereotactic radiotherapy or three-dimensional conformal radiotherapy.

Authors:  Chun-Shu Lin; Yee-Min Jen; Su-Yun Chiu; Jing-Min Hwang; Hsing-Lung Chao; Hon-Yi Lin; Weng-Yoon Shum
Journal:  Jpn J Clin Oncol       Date:  2006-04-13       Impact factor: 3.019

7.  Portal vein thrombosis in hepatocellular carcinoma: age and sex distribution in an autopsy study.

Authors:  M Pirisi; C Avellini; C Fabris; C Scott; P Bardus; G Soardo; C A Beltrami; E Bartoli
Journal:  J Cancer Res Clin Oncol       Date:  1998       Impact factor: 4.553

8.  The treatment responses in cases of radiation therapy to portal vein thrombosis in advanced hepatocellular carcinoma.

Authors:  Yu-Jie Huang; Hsuan-Chih Hsu; Chang-Yu Wang; Chong-Jong Wang; Hui-Chun Chen; Eng-Yen Huang; Fu-Min Fang; Sheng-Nan Lu
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-08-28       Impact factor: 7.038

9.  Hypofractionated stereotactic radiotherapy with and without transarterial chemoembolization for small hepatocellular carcinoma not eligible for other ablation therapies: Preliminary results for efficacy and toxicity.

Authors:  Atsuya Takeda; Masahiko Takahashi; Etsuo Kunieda; Toshiaki Takeda; Naoko Sanuki; Yuji Koike; Kazuhiro Atsukawa; Toshio Ohashi; Hidetsugu Saito; Naoyuki Shigematsu; Atsushi Kubo
Journal:  Hepatol Res       Date:  2007-05-15       Impact factor: 4.288

10.  Stereotactic body radiation therapy with or without transarterial chemoembolization for patients with primary hepatocellular carcinoma: preliminary analysis.

Authors:  Byung Ock Choi; Ihl Bohng Choi; Hong Seok Jang; Young Nam Kang; Ji Sun Jang; Si Hyun Bae; Seung Kew Yoon; Gyu Young Chai; Ki Mun Kang
Journal:  BMC Cancer       Date:  2008-11-27       Impact factor: 4.430
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.